Table 1: The reported dose, number, and sites of botulinum toxin Type A injections and therapeutic efficacy and adverse events in patients with spinal cord injured and neurogenic lower urinary tract dysfunction
| Close | |
|
|
|
|
Table 1: The reported dose, number, and sites of botulinum toxin Type A injections and therapeutic efficacy and adverse events in patients with spinal cord injured and neurogenic lower urinary tract dysfunction
|
|